NO953760L - Ekspresjon av heterologe polypeptider i halobakterier - Google Patents

Ekspresjon av heterologe polypeptider i halobakterier

Info

Publication number
NO953760L
NO953760L NO953760A NO953760A NO953760L NO 953760 L NO953760 L NO 953760L NO 953760 A NO953760 A NO 953760A NO 953760 A NO953760 A NO 953760A NO 953760 L NO953760 L NO 953760L
Authority
NO
Norway
Prior art keywords
halobacteria
expression
heterologous polypeptides
heterologous
polypeptides
Prior art date
Application number
NO953760A
Other languages
English (en)
Norwegian (no)
Other versions
NO953760D0 (no
Inventor
George J Turner
Mary C Betlach
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of NO953760D0 publication Critical patent/NO953760D0/no
Publication of NO953760L publication Critical patent/NO953760L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/215—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Halobacteriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Neurology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
NO953760A 1993-03-25 1995-09-22 Ekspresjon av heterologe polypeptider i halobakterier NO953760L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3866293A 1993-03-25 1993-03-25
PCT/US1994/002388 WO1994021789A1 (en) 1993-03-25 1994-02-28 Expression of heterologous polypeptides in halobacteria

Publications (2)

Publication Number Publication Date
NO953760D0 NO953760D0 (no) 1995-09-22
NO953760L true NO953760L (no) 1995-09-22

Family

ID=21901190

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953760A NO953760L (no) 1993-03-25 1995-09-22 Ekspresjon av heterologe polypeptider i halobakterier

Country Status (9)

Country Link
US (2) US5641650A (ja)
EP (1) EP0690913A1 (ja)
JP (1) JPH08508162A (ja)
AU (1) AU682508B2 (ja)
CA (1) CA2156251A1 (ja)
FI (1) FI954534A (ja)
NO (1) NO953760L (ja)
PL (1) PL176653B1 (ja)
WO (1) WO1994021789A1 (ja)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6268216B1 (en) * 1998-07-27 2001-07-31 Case Western Reserve University Reagents and methods for the screening of compounds useful in the treatment of neurological diseases
US20040248202A1 (en) * 1998-09-03 2004-12-09 Wisconsin Alumni Research Foundation Bacteriorhodopsin/G protein-coupled receptor chimeras
US8906360B2 (en) * 2005-07-22 2014-12-09 The Board Of Trustees Of The Leland Stanford Junior University Light-activated cation channel and uses thereof
US9238150B2 (en) 2005-07-22 2016-01-19 The Board Of Trustees Of The Leland Stanford Junior University Optical tissue interface method and apparatus for stimulating cells
US9274099B2 (en) 2005-07-22 2016-03-01 The Board Of Trustees Of The Leland Stanford Junior University Screening test drugs to identify their effects on cell membrane voltage-gated ion channel
US20090093403A1 (en) 2007-03-01 2009-04-09 Feng Zhang Systems, methods and compositions for optical stimulation of target cells
US8926959B2 (en) * 2005-07-22 2015-01-06 The Board Of Trustees Of The Leland Stanford Junior University System for optical stimulation of target cells
US10052497B2 (en) * 2005-07-22 2018-08-21 The Board Of Trustees Of The Leland Stanford Junior University System for optical stimulation of target cells
US8398692B2 (en) 2007-01-10 2013-03-19 The Board Of Trustees Of The Leland Stanford Junior University System for optical stimulation of target cells
WO2008101128A1 (en) * 2007-02-14 2008-08-21 The Board Of Trustees Of The Leland Stanford Junior University System, method and applications involving identification of biological circuits such as neurological characteristics
CN101285069B (zh) * 2007-04-09 2012-04-25 武汉大学 细菌视紫红质多位点突变基因和蛋白质及制备方法和应用
US10434327B2 (en) * 2007-10-31 2019-10-08 The Board Of Trustees Of The Leland Stanford Junior University Implantable optical stimulators
US10035027B2 (en) * 2007-10-31 2018-07-31 The Board Of Trustees Of The Leland Stanford Junior University Device and method for ultrasonic neuromodulation via stereotactic frame based technique
EP2281039B1 (en) 2008-04-23 2016-09-28 The Board of Trustees of the Leland Stanford Junior University Systems, methods and compositions for optical stimulation of target cells
MY152003A (en) 2008-05-29 2014-08-15 Univ Leland Stanford Junior Cell line, system and method for optical control of secondary messengers
EP2303406B1 (en) * 2008-06-17 2016-11-09 The Board of Trustees of the Leland Stanford Junior University Devices for optical stimulation of target cells using an optical transmission element
CA2728402A1 (en) * 2008-06-17 2009-12-23 The Board Of Trustees Of The Leland Stanford Junior University Apparatus and methods for controlling cellular development
WO2010006049A1 (en) 2008-07-08 2010-01-14 The Board Of Trustees Of The Leland Stanford Junior University Materials and approaches for optical stimulation of the peripheral nervous system
NZ602416A (en) 2008-11-14 2014-08-29 Univ Leland Stanford Junior Optically-based stimulation of target cells and modifications thereto
AU2011227131B2 (en) * 2010-03-17 2014-11-13 The Board Of Trustees Of The Leland Stanford Junior University Light-sensitive ion-passing molecules
ES2661093T3 (es) 2010-11-05 2018-03-27 The Board Of Trustees Of The University Of The Leland Stanford Junior University Control y caracterización de la función de la memoria
AU2011323226B2 (en) 2010-11-05 2015-03-12 The Board Of Trustees Of The Leland Stanford Junior University Light-activated chimeric opsins and methods of using the same
CN103476456B (zh) 2010-11-05 2017-10-03 斯坦福大学托管董事会 奖赏相关行为的光遗传学控制
ES2690172T3 (es) 2010-11-05 2018-11-19 The Board Of Trustees Of The Leland Stanford Junior University Conversión ascendente de la luz para su uso en métodos optogenéticos
WO2012061690A2 (en) 2010-11-05 2012-05-10 The Board Of Trustees Of The Leland Stanford Junior University Optically-controlled cns dysfunction
CN105941328B (zh) 2010-11-05 2019-04-09 斯坦福大学托管董事会 一种鉴定抑制前额叶皮质中的兴奋性或抑制性神经元的去极化的化合物的系统
US8696722B2 (en) 2010-11-22 2014-04-15 The Board Of Trustees Of The Leland Stanford Junior University Optogenetic magnetic resonance imaging
AU2012352429B2 (en) 2011-12-16 2018-07-19 The Board Of Trustees Of The Leland Stanford Junior University Opsin polypeptides and methods of use thereof
WO2013126521A1 (en) 2012-02-21 2013-08-29 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for treating neurogenic disorders of the pelvic floor
US9067985B2 (en) * 2012-10-06 2015-06-30 Academia Sinica Bacteriorhodopsin fusion membrane protein expression system
US9636380B2 (en) 2013-03-15 2017-05-02 The Board Of Trustees Of The Leland Stanford Junior University Optogenetic control of inputs to the ventral tegmental area
ES2742492T3 (es) 2013-03-15 2020-02-14 Univ Leland Stanford Junior Control optogenético del estado conductual
US10220092B2 (en) 2013-04-29 2019-03-05 The Board Of Trustees Of The Leland Stanford Junior University Devices, systems and methods for optogenetic modulation of action potentials in target cells
WO2015023782A1 (en) 2013-08-14 2015-02-19 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for controlling pain
US10568516B2 (en) 2015-06-22 2020-02-25 The Board Of Trustees Of The Leland Stanford Junior University Methods and devices for imaging and/or optogenetic control of light-responsive neurons
US11294165B2 (en) 2017-03-30 2022-04-05 The Board Of Trustees Of The Leland Stanford Junior University Modular, electro-optical device for increasing the imaging field of view using time-sequential capture
US10828262B2 (en) * 2017-07-19 2020-11-10 Hangzhou UMotor Biotech Co., LTD. Biomembrane, closed structure with biomembrane characteristics or cellular compartment derived from natural sources and/or self-assembly techniques, preparation method and applications thereof
CN109652433A (zh) * 2018-12-19 2019-04-19 南京理工大学 可视化的离子通道蛋白bR可溶性融合表达载体及其构建方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0634724B2 (ja) * 1982-08-25 1994-05-11 三菱化成株式会社 プラスミド
JPH03151883A (ja) * 1989-11-08 1991-06-28 Canon Inc 形質転換法

Also Published As

Publication number Publication date
NO953760D0 (no) 1995-09-22
PL176653B1 (pl) 1999-07-30
EP0690913A1 (en) 1996-01-10
CA2156251A1 (en) 1994-09-29
US5641650A (en) 1997-06-24
FI954534A0 (fi) 1995-09-25
WO1994021789A1 (en) 1994-09-29
PL310557A1 (en) 1995-12-27
JPH08508162A (ja) 1996-09-03
AU6587594A (en) 1994-10-11
AU682508B2 (en) 1997-10-09
FI954534A (fi) 1995-09-25
US6010885A (en) 2000-01-04

Similar Documents

Publication Publication Date Title
NO953760L (no) Ekspresjon av heterologe polypeptider i halobakterier
EP0861893A3 (en) High level expression of immunoglobulin polypeptides
DE69311160D1 (de) Photochromische Zusammensetzung
DE69403801D1 (de) Kosmetische zusammensetzung
FI945657A (fi) Proteesi
IT1232848B (it) Composizione di sciampo limpido
DE69220382D1 (de) Verwendung von Peptidderivaten
DK162890D0 (da) Polypeptid
NO932148D0 (no) Fusjonspolypeptider
LV11017A (lv) Trisslanu panelu nepartrauktas izgatavosanas iekartaun panemiens
GB9108406D0 (en) Chord members for bailey bridges and panels incorporating such members
DE69603508D1 (de) Solubilisierungsverfahren von bezotriazol mit thiadiazol
FI935559A0 (fi) Foerfarande foer faestning av haordmetallstift i en borrkrona och en borrkrona
FI933412A (fi) Foerfarande foer aotervinning av organiskt material i extraktionsprocesser
DK196689D0 (da) Ekspression af praes2-proteinet for hepatitis b i methylotrophe gaerarter
DK319089D0 (da) Carbonylforbindelse
KR940022779U (ko) 수문용 패킹
DK0587480T3 (da) Deponeringsindretning
LV10576A (lv) Arstnieciska kompozicija
LV10838A (lv) Arstnieciska kompozicija
NO914130D0 (no) Forbedret ekspresjon av polypeptider
KR940024458U (ko) 수세미의 봉함구조
KR940019143U (ko) 인조나무형 구조물
SE9300722D0 (sv) Novel polypeptides ii
FI933513A0 (fi) Foerfarande foer installering av en gaongskena i en elapparatstomme och elapparatstomme

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application